Literature DB >> 25970319

Induction of thermal and mechanical hypersensitivity by parathyroid hormone-related peptide through upregulation of TRPV1 function and trafficking.

Aaron D Mickle1, Andrew J Shepherd, Lipin Loo, Durga P Mohapatra.   

Abstract

The neurobiological mechanisms underlying chronic pain associated with cancers are not well understood. It has been hypothesized that factors specifically elevated in the tumor microenvironment sensitize adjacent nociceptive afferents. We show that parathyroid hormone-related peptide (PTHrP), which is found at elevated levels in the tumor microenvironment of advanced breast and prostate cancers, is a critical modulator of sensory neurons. Intraplantar injection of PTHrP led to the development of thermal and mechanical hypersensitivity in both male and female mice, which were absent in mice lacking functional transient receptor potential vanilloid-1 (TRPV1). The PTHrP treatment of cultured mouse sensory neurons enhanced action potential firing, and increased TRPV1 activation, which was dependent on protein kinase C (PKC) activity. Parathyroid hormone-related peptide induced robust potentiation of TRPV1 activation and enhancement of neuronal firing at mild acidic pH that is relevant to acidic tumor microenvironment. We also observed an increase in plasma membrane TRPV1 protein levels after exposure to PTHrP, leading to upregulation in the proportion of TRPV1-responsive neurons, which was dependent on the activity of PKC and Src kinases. Furthermore, co-injection of PKC or Src inhibitors attenuated PTHrP-induced thermal but not mechanical hypersensitivity. Altogether, our results suggest that PTHrP and mild acidic conditions could induce constitutive pathological activation of sensory neurons through upregulation of TRPV1 function and trafficking, which could serve as a mechanism for peripheral sensitization of nociceptive afferents in the tumor microenvironment.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25970319      PMCID: PMC5070921          DOI: 10.1097/j.pain.0000000000000224

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   7.926


  90 in total

1.  Modulation of acid-sensing ion channels: molecular mechanisms and therapeutic potential.

Authors:  Xiang-Ping Chu; Christopher J Papasian; John Q Wang; Zhi-Gang Xiong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-11-18

Review 2.  Molecular biology of bone metastasis.

Authors:  Lauren A Kingsley; Pierrick G J Fournier; John M Chirgwin; Theresa A Guise
Journal:  Mol Cancer Ther       Date:  2007-10       Impact factor: 6.261

Review 3.  Pharmacologic management of cancer pain.

Authors:  Gregory H Pharo; Linqiu Zhou
Journal:  J Am Osteopath Assoc       Date:  2005-11

4.  Differential contribution of Kv4-containing channels to A-type, voltage-gated potassium currents in somatic and visceral dorsal root ganglion neurons.

Authors:  Takakazu Yunoki; Koichi Takimoto; Kaori Kita; Yasuhito Funahashi; Ryosuke Takahashi; Hiroko Matsuyoshi; Seiji Naito; Naoki Yoshimura
Journal:  J Neurophysiol       Date:  2014-08-20       Impact factor: 2.714

5.  Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease.

Authors:  Cheryl A Hillery; Patrick C Kerstein; Daniel Vilceanu; Marie E Barabas; Dawn Retherford; Amanda M Brandow; Nancy J Wandersee; Cheryl L Stucky
Journal:  Blood       Date:  2011-06-27       Impact factor: 22.113

Review 6.  Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy.

Authors:  Wende Kozlow; Theresa A Guise
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-04       Impact factor: 2.673

7.  Involvement of TRPV1 in nociceptive behavior in a rat model of cancer pain.

Authors:  Masamichi Shinoda; Akina Ogino; Noriyuki Ozaki; Hiroko Urano; Katsunori Hironaka; Masaya Yasui; Yasuo Sugiura
Journal:  J Pain       Date:  2008-05-02       Impact factor: 5.820

8.  p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia.

Authors:  Ru-Rong Ji; Tarek A Samad; Shan-Xue Jin; Raymond Schmoll; Clifford J Woolf
Journal:  Neuron       Date:  2002-09-26       Impact factor: 17.173

9.  Nerve growth factor induces sensitization of nociceptors without evidence for increased intraepidermal nerve fiber density.

Authors:  Michael Hirth; Roman Rukwied; Alois Gromann; Brian Turnquist; Benjamin Weinkauf; Klaus Francke; Philip Albrecht; Frank Rice; Björn Hägglöf; Matthias Ringkamp; Maren Engelhardt; Christian Schultz; Martin Schmelz; Otilia Obreja
Journal:  Pain       Date:  2013-07-26       Impact factor: 6.961

10.  Involvement of lysophosphatidic acid in bone cancer pain by potentiation of TRPV1 via PKCε pathway in dorsal root ganglion neurons.

Authors:  Hai-Li Pan; Yu-Qiu Zhang; Zhi-Qi Zhao
Journal:  Mol Pain       Date:  2010-12-01       Impact factor: 3.395

View more
  18 in total

Review 1.  Neuronal transient receptor potential (TRP) channels and noxious sensory detection in sickle cell disease.

Authors:  Katelyn E Sadler; Cheryl L Stucky
Journal:  Neurosci Lett       Date:  2018-11-30       Impact factor: 3.046

2.  Female-Specific Effects of CGRP Suggest Limited Efficacy of New Migraine Treatments in Males.

Authors:  Francie Moehring; Katelyn E Sadler
Journal:  J Neurosci       Date:  2019-11-13       Impact factor: 6.167

3.  Anti-vascular endothelial growth factor treatment decreases bladder pain in cyclophosphamide cystitis: a Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network animal model study.

Authors:  H Henry Lai; Baixin Shen; Pooja Vijairania; Xiaowei Zhang; Sherri K Vogt; Robert W Gereau
Journal:  BJU Int       Date:  2017-06-29       Impact factor: 5.588

4.  Angiotensin II Triggers Peripheral Macrophage-to-Sensory Neuron Redox Crosstalk to Elicit Pain.

Authors:  Andrew J Shepherd; Bryan A Copits; Aaron D Mickle; Páll Karlsson; Suraj Kadunganattil; Simon Haroutounian; Satya M Tadinada; Annette D de Kloet; Manouela V Valtcheva; Lisa A McIlvried; Tayler D Sheahan; Sanjay Jain; Pradipta R Ray; Yuriy M Usachev; Gregory Dussor; Eric G Krause; Theodore J Price; Robert W Gereau; Durga P Mohapatra
Journal:  J Neurosci       Date:  2018-07-05       Impact factor: 6.167

5.  Role of Src kinase in regulating protein kinase C mediated phosphorylation of TRPV1.

Authors:  Gabriella L Robilotto; Durga P Mohapatra; Andrew J Shepherd; Aaron D Mickle
Journal:  Eur J Pain       Date:  2022-08-04       Impact factor: 3.651

6.  Examining the Reversibility of Long-Term Behavioral Disruptions in Progeny of Maternal SSRI Exposure.

Authors:  Susan E Maloney; Shyam Akula; Michael A Rieger; Katherine B McCullough; Krystal Chandler; Adrian M Corbett; Audrey E McGowin; Joseph D Dougherty
Journal:  eNeuro       Date:  2018-07-09

7.  The Complement System Component C5a Produces Thermal Hyperalgesia via Macrophage-to-Nociceptor Signaling That Requires NGF and TRPV1.

Authors:  Leonid P Shutov; Charles A Warwick; Xiaoyu Shi; Aswini Gnanasekaran; Andrew J Shepherd; Durga P Mohapatra; Trent M Woodruff; J David Clark; Yuriy M Usachev
Journal:  J Neurosci       Date:  2016-05-04       Impact factor: 6.167

8.  Macrophage angiotensin II type 2 receptor triggers neuropathic pain.

Authors:  Andrew J Shepherd; Aaron D Mickle; Judith P Golden; Madison R Mack; Carmen M Halabi; Annette D de Kloet; Vijay K Samineni; Brian S Kim; Eric G Krause; Robert W Gereau; Durga P Mohapatra
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-06       Impact factor: 11.205

9.  Pharmacological validation of voluntary gait and mechanical sensitivity assays associated with inflammatory and neuropathic pain in mice.

Authors:  Andrew J Shepherd; Durga P Mohapatra
Journal:  Neuropharmacology       Date:  2017-11-27       Impact factor: 5.250

10.  Mechanisms underlying mechanical sensitization induced by complement C5a: the roles of macrophages, TRPV1, and calcitonin gene-related peptide receptors.

Authors:  Charles A Warwick; Leonid P Shutov; Andrew J Shepherd; Durga P Mohapatra; Yuriy M Usachev
Journal:  Pain       Date:  2019-03       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.